Advertisement

Topics

Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO

19:00 EST 13 Nov 2017 | BioSpace

The company has raised $350 million and gathered a portfolio of drugs targeting neurodegenerative diseases in just two and a half years.

Original Article: Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO

NEXT ARTICLE

More From BioPortfolio on "Run by Former Genentech Employees, Bay Area's Denali Seeks $100M IPO"

Advertisement
Quick Search
Advertisement
Advertisement